Management of non ST-elevation acute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012

N Z Med J. 2016 Jan 8;129(1428):10-6.

Abstract

Aims: The first New Zealand Acute Coronary Syndrome (ACS) national audit of 2002 was a collaborative effort between clinicians and nurses, and demonstrated important limitations to Non ST-elevation ACS patient (NSTEACS) care. A momentum for change was created. Subsequent audits in 2007 and 2012 allow assessment over time.

Methods: Over 14 days in May 2002, 2007 and 2012, patients with suspected ACS admitted to a hospital in New Zealand were audited. 'Definite' ACS was determined at discharge, after in-hospital investigations; we reviewed NSTEACS patients.

Results: From 2002, more patients underwent assessment of left ventricular function (echocardiogram) and coronary angiography. Evidence-based in-hospital medical treatments and revascularisation have also increased over the decade.

Conclusions: Over a ten-year period, evidence-based care for patients presenting with a NSTEACS event in New Zealand has improved. However, considerable room remains to optimise management, particularly with development of systems of care to facilitate prompt referral and delivery of angiography in these high-risk individuals.

Publication types

  • Multicenter Study

MeSH terms

  • Acute Coronary Syndrome / epidemiology*
  • Acute Coronary Syndrome / therapy*
  • Adrenergic beta-Antagonists / therapeutic use
  • Age Distribution
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Clinical Audit*
  • Coronary Angiography / statistics & numerical data
  • Coronary Angiography / trends
  • Coronary Artery Bypass / statistics & numerical data
  • Coronary Artery Bypass / trends
  • Diabetes Mellitus / epidemiology
  • Drug Utilization / statistics & numerical data
  • Drug Utilization / trends
  • Echocardiography / statistics & numerical data
  • Echocardiography / trends
  • Ethnicity / statistics & numerical data
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Longitudinal Studies
  • Male
  • New Zealand / epidemiology
  • Patient Admission
  • Percutaneous Coronary Intervention / statistics & numerical data
  • Percutaneous Coronary Intervention / trends
  • Platelet Aggregation Inhibitors / therapeutic use
  • Racial Groups / statistics & numerical data

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors